Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07755059
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated CirrhosisMassachusetts General HospitalNot Yet RecruitingNot Applicable
NCT07755059Not Yet Recruiting
Not Applicable
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Asci...Massachusetts General Hos...
NCT07756229
Clinical and Brain Activity Assessment Before and After Physiotherapy in People With Chronic Non-specific Neck PainAnder Cervantes BenítezRecruitingNot Applicable
NCT07756229Recruiting
Not Applicable
Clinical and Brain Activity Assessment Before and After Physiotherapy in People...Ander Cervantes Benítez
NCT07753954
Medical Imaging to Re-evaluate Elacestrant Clinical UsageGE HealthcareNot Yet RecruitingPhase 2
NCT07753954Not Yet Recruiting
Phase 2
Medical Imaging to Re-evaluate Elacestrant Clinical UsageGE Healthcare
NCT07756580
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar LinesAbbVieNot Yet RecruitingPhase 1
NCT07756580Not Yet Recruiting
Phase 1
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Follow...AbbVie
NCT07756242
Pharmacokinetic Study of Therapeutic Plasma ExchangeUniversity of ChicagoNot Yet Recruiting
NCT07756242Not Yet Recruiting
—
Pharmacokinetic Study of Therapeutic Plasma ExchangeUniversity of Chicago
NCT07754006
Preliminary Clinical Feasibility Study of a Medical Device Enabling Brain Access Using Microbubble-Enhanced SonicationGustave Roussy, Cancer Campus, Grand ParisNot Yet RecruitingPhase 1
NCT07754006Not Yet Recruiting
Phase 1
Preliminary Clinical Feasibility Study of a Medical Device Enabling Brain Access...Gustave Roussy, Cancer Ca...
NCT07754890
Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma Phase I/II TrialPeking Union Medical College HospitalRecruitingPhase 1
NCT07754890Recruiting
Phase 1
Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma Phase I/II TrialPeking Union Medical Coll...
NCT07755787
Ultrasound Assessment of Pediatric Fracture Healing With the PLUS ScoreMasaryk UniversityNot Yet Recruiting
NCT07755787Not Yet Recruiting
—
Ultrasound Assessment of Pediatric Fracture Healing With the PLUS ScoreMasaryk University
NCT07756554
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital AdmissionAmager HospitalRecruitingNot Applicable
NCT07756554Recruiting
Not Applicable
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospi...Amager Hospital
NCT07754721
Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study of Multidimensional Interventions and Health ImpactsHualien Tzu Chi General HospitalRecruitingNot Applicable
NCT07754721Recruiting
Not Applicable
Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study...Hualien Tzu Chi General H...
NCT07755813
Pirfenidone as Treatment of Chronic PancreatitisUnited States Department of DefenseNot Yet RecruitingPhase 2
NCT07755813Not Yet Recruiting
Phase 2
Pirfenidone as Treatment of Chronic PancreatitisUnited States Department...
NCT07755332
Association Between Central Sensitization and the Root Mean Square of Successive DifferencesIstanbul Demiroglu Bilim UniversityCompleted
NCT07755332Completed
—
Association Between Central Sensitization and the Root Mean Square of Successive...Istanbul Demiroglu Bilim...
NCT07755605
Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder: A Randomized Controlled TrialSamsung Medical CenterRecruitingNot Applicable
NCT07755605Recruiting
Not Applicable
Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Dis...Samsung Medical Center
NCT07755631
The BASIC-S Feasibility Study for Vascular Risk ReductionAcademic Medical Organization of Southwestern OntarioNot Yet RecruitingNot Applicable
NCT07755631Not Yet Recruiting
Not Applicable
The BASIC-S Feasibility Study for Vascular Risk ReductionAcademic Medical Organiza...
NCT07754578
DOSE-UP: Dose Optimization for Smoking and E-Cigarette Use PharmacotherapyMedical University of South CarolinaNot Yet RecruitingPhase 2
NCT07754578Not Yet Recruiting
Phase 2
DOSE-UP: Dose Optimization for Smoking and E-Cigarette Use PharmacotherapyMedical University of Sou...
NCT07754877
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter StudyPeking University Aerospace Center HospitalNot Yet RecruitingNot Applicable
NCT07754877Not Yet Recruiting
Not Applicable
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combin...Peking University Aerospa...
NCT07753928
PENTAGON: MS-Related Disability Worsening and Thalamic Volume LossJung Diagnostics GmbHEnrolling By Invitation
NCT07753928Enrolling By Invitation
—
PENTAGON: MS-Related Disability Worsening and Thalamic Volume LossJung Diagnostics GmbH
NCT07754292
Off-Label Treatment With Immune Checkpoint Inhibitor BlockadeMedical College of WisconsinNot Yet RecruitingPhase 2
NCT07754292Not Yet Recruiting
Phase 2
Off-Label Treatment With Immune Checkpoint Inhibitor BlockadeMedical College of Wiscon...
NCT07754760
Essential Amino Acid Supplementation Enhances Post-prandial Amino Acid Availability Following a Standard-protein Breakfast in Older AdultsLeeds Beckett UniversityCompletedNot Applicable
NCT07754760Completed
Not Applicable
Essential Amino Acid Supplementation Enhances Post-prandial Amino Acid Availabil...Leeds Beckett University
NCT07754448
Libre Del Cigarrillo: Development of an mHealth Smoking Cessation App to Extend Reach of a Validated Smoking Cessation Intervention for Spanish-speaking SmokersH. Lee Moffitt Cancer Center and Research InstituteNot Yet RecruitingNot Applicable
NCT07754448Not Yet Recruiting
Not Applicable
Libre Del Cigarrillo: Development of an mHealth Smoking Cessation App to Extend...H. Lee Moffitt Cancer Cen...
Result Breakdown
Not yet recruiting12 (60%)
Recruiting5 (25%)
Completed2 (10%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Phase 24 (20%)
Not Specified4 (20%)
Phase 13 (15%)